Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Regev

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
American Journal of Medical Genetics|August 1, 1985
Krabbe disease: increased incidence in a highly inbred communityJ Zlotogora, R Regev, M Zeigler, et al.
The Journal of Pediatrics|September 1, 1987
Cerebral ventricular dilation in congenital myotonic dystrophyR Regev, L S de Vries, J Z Heckmatt, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 15, 1984
Prenatal diagnosis of Krabbe disease using a fluorescent derivative of galactosylceramideM Zeigler, J Zlotogora, R Regev, et al.
Harefuah|November 15, 1990
[The handicapped newborn infant: an experienced multidisciplinary team approach for family support]M Katzenstein, R Regev, N Wogera, et al.
Early Human Development|August 1, 1988
Evolution of periventricular leukomalacia during the neonatal period and infancy: correlation of imaging and postmortem findingsL S De Vries, J S Wigglesworth, R Regev, et al.
Journal of Perinatal Medicine|June 24, 1999
Familial perinatal hemochromatosis: a disease that causes recurrent non-immune hydropsE Kassem, T Dolfin, I Litmanowitz, et al.
Israel Journal of Medical Sciences|October 1, 1983
Perinatal group B streptococcal infections in IsraelZ Weintraub, R Regev, T C Iancu, et al.
Paediatric and Perinatal Epidemiology|August 8, 2001
Preterm labour at 34--36 weeks of gestation: should it be arrested?S Arnon, T Dolfin, I Litmanovitz, et al.
Lancet (London, England)|March 14, 1987
Dexamethasone and increased intracranial echogenicityR Regev, L S de Vries, C M Noble-Jamieson, et al.
European Journal of Biochemistry|August 15, 1997
Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rateG D Eytan, R Regev, G Oren, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
American Journal of Medical Genetics|August 1, 1985
Krabbe disease: increased incidence in a highly inbred communityJ Zlotogora, R Regev, M Zeigler, et al.
The Journal of Pediatrics|September 1, 1987
Cerebral ventricular dilation in congenital myotonic dystrophyR Regev, L S de Vries, J Z Heckmatt, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 15, 1984
Prenatal diagnosis of Krabbe disease using a fluorescent derivative of galactosylceramideM Zeigler, J Zlotogora, R Regev, et al.
Harefuah|November 15, 1990
[The handicapped newborn infant: an experienced multidisciplinary team approach for family support]M Katzenstein, R Regev, N Wogera, et al.
Early Human Development|August 1, 1988
Evolution of periventricular leukomalacia during the neonatal period and infancy: correlation of imaging and postmortem findingsL S De Vries, J S Wigglesworth, R Regev, et al.
Journal of Perinatal Medicine|June 24, 1999
Familial perinatal hemochromatosis: a disease that causes recurrent non-immune hydropsE Kassem, T Dolfin, I Litmanowitz, et al.
Israel Journal of Medical Sciences|October 1, 1983
Perinatal group B streptococcal infections in IsraelZ Weintraub, R Regev, T C Iancu, et al.
Paediatric and Perinatal Epidemiology|August 8, 2001
Preterm labour at 34--36 weeks of gestation: should it be arrested?S Arnon, T Dolfin, I Litmanovitz, et al.
Lancet (London, England)|March 14, 1987
Dexamethasone and increased intracranial echogenicityR Regev, L S de Vries, C M Noble-Jamieson, et al.
European Journal of Biochemistry|August 15, 1997
Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rateG D Eytan, R Regev, G Oren, et al.
Pageof 5